Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04017650
Title	Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	M.D. Anderson Cancer Center
Indications	colon adenocarcinoma rectum adenocarcinoma
Therapies	Cetuximab + Encorafenib + Nivolumab
Age Groups:	senior \| adult
Covered Countries	USA